Dariohealth demonstrates continued growth in multi-chronic contracts with latest addition of a national employer for the full solution suite

Demand for dario's single approach to chronic condition management continues to show strong demand new york , july 21, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, today announced a new contract to deliver its full suite of integrated chronic condition management solutions to a national employer.  the new account is expected to launch in the third quarter of 2022.
DRIO Ratings Summary
DRIO Quant Ranking